Our previous analysis of data sets from The Cancer Genome Atlas and our own immunohistochemical analysis revealed that low expression of TMIGD1 correlates with poor survival in renal and colon cancers [10, 27]. This evidence concerns the gene TMIGD1 and colonic neoplasm.